borderline significancep = 0.051
Notably, comparative CRP reduction d21–d3 in digoxin versus the control group also revealed borderline significance ( p = 0.051).
Notably, comparative CRP reduction d21–d3 in digoxin versus the control group also revealed borderline significance ( p = 0.051).
The primary endpoint, i.e., CRP plasma level reduction d21–d3, is of borderline significance ( p = 0.051) only.